openPR Logo
Press release

Testicular Cancer Drugs Market: Technologies, Markets and Players

05-15-2017 09:46 PM CET | Health & Medicine

Press release from: Transparency Market Research

Testicular Cancer Drugs Market: Technologies, Markets

Some of the key players in the global testicular cancer drugs market include Bristol-Myers Squibb Co., Hospira Inc., Ovation Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., ZIOPHARM Oncology Inc., Fresenius Kabi AG and Teva Parenteral Medicines, Inc.

Testicular cancer is observed in males aged between 15 to 44 years where major symptoms include forming a painless lump or swelling in testicles. If the cancer is left untreated, the eventual course is metastasis and mortality. However, due to advances in multimodal treatments which include surgery, radiation and chemotherapy, a cure for this type of cancer is commonly achieved. Testicular cancer is classified into different types of cancer depending on the type cell in which cancer begins. Cancer developed in germ cells is termed as germ cell testicular cancer and is the most common type. Germ cell testicular cancers account for more than 95% of all testicular cancer cases and are further segmented into seminomas and non-seminomas which approximately account for 40% and 60% of total germ cell testicular cancer. The other less prevalent types of testicular cancers include include Leydig cell tumors (1% to 3%) and Sertoli cell tumors (less than 1%). The treatment of testicular cancer is determined on the type of cancer and the level of advancement of tumor within the body.

View Report @ http://www.transparencymarketresearch.com/testicular-cancer-drugs-market.html

Testicular cancer itself is a relatively uncommon and accounts for less than 1 percent of all types of cancer incidences. Globally the cancer is more prevalent in the developed regions which include Australia, North America and Europe. In 2011, approximately 2,207 men in the U.K. were diagnosed with testicular cancer while 68 men died from this disease. The American Cancer Society estimates that in 2014 about 8,820 new cases of testicular cancer will be diagnosed and 380 deaths will occur in the U.S. The rate of incidences of testicular cancer has been observed to be rising every year across the world, however the curability of this disease has increased the survival rate of patients affecting with it. For instance, only four percent of testicular cancer patients in the U.S. die within first five years of getting the disease. Hence, more people are getting treated each year with this type of cancer which reflects the growth of the global testicular cancer drugs market.

Get accurate market forecast and analysis on the Testicular Cancer Drugs Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8206

The global testicular cancer drugs market is classified on the basis of cancer types into three segments, namely germ cell cancer drugs market, Leydig cell cancer drugs market and Sertoli cell cancers market. The main drugs used in treating testicular cancer are cisplatin, etoposide, ifosfamide, paclitaxel, and vinblastine. Other drugs used for treating testicular cancer include bleomycin, dactinomycin. The treatment is more effective if the chemotherapy regimen involve 2 or more drugs rather than using any single drug. The common chemotherapy regimens for treatment of testicular cancer are BEP (bleomycin, etoposide, and cisplatin), EP (etoposide and cisplatin), TIP (paclitaxel, ifosfamide, and cisplatin), and VIP (VP-16/etoposide or vinblastin, ifosfamide and cisplatin). Some of these drugs can have serious side effects such as kidney damage, lung damage, neuropathy, and hemorrhagic cystitis and therefore have to be administered with utmost care and monitoring the effects of these drugs. However, the side effects last shortly and do not affect the patient permanently unless the dosage regimens include very high doses for ling duration.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Testicular Cancer Drugs Market: Technologies, Markets and Players here

News-ID: 537307 • Views: 364

More Releases from Transparency Market Research

Vacuum Blood Collection Tube Market Size, Competitors Strategy, Regional Analysi …
Vacuum Blood Collection Tube Market: Overview A vacuum blood collection tube is a sterile glass or plastic test tube that uses a stopper to create a vacuum seal inside the tube and enable the depiction of a predetermined volume of liquid. The vacuum blood collection tube prevents needle stick damage by preventing needles from coming in human contact and thus, contamination. Read Report Overview - https://www.transparencymarketresearch.com/vacuum-blood-collection-tube-market.html The vacuum blood collection tube contains a
Vitrectomy Devices Market Trends, Revenue, Key Players, Growth, Share and Foreca …
Vitrectomy Systems Market: Introduction Retina is a layer of nerve tissue lining the back of the eye. It receives light and converts it into neural signals and sends these signals to the brain for visual recognition. There are several types of retinal diseases affecting the retina, including retinal detachment, macular pucker or hole, diabetic retinopathy, and vitreous hemorrhage Read Report Overview - https://www.transparencymarketresearch.com/vitrectomy-systems-market.html Vitrectomy is a surgical procedure, which removes the vitreous gel that
Dental Articulators Market is Expected to Witness Significant Growth between 202 …
Dental Articulators Market: Introduction The key to a successful and long-lasting dental restoration process is to adequately diagnose the issue and plan a treatment process An articulator is a mechanical hinged device to which casts of maxillary (upper) and mandibular (lower) jaws are fixed, reproducing some or all the movements of the mandible in relation to the maxilla Read Report Overview - https://www.transparencymarketresearch.com/dental-articulators-market.html Articulators have been a true asset for dentists across the world,
Expansion of Block Bottom Bags Market - worldwide statistics & facts 2021 - 2031
Block Bottom Bags Market: Introduction In terms of revenue, the global block bottom bags market is projected to grow at a CAGR of 4.8% during the forecast period of 2021-2029, owing to several factors, about which TMR offers detailed insights and forecasts in the block bottom bags market report. Block bottom bags are in high demand in the market, as they provide shelf stability to their solid level bottom. The secure foundation

All 5 Releases


More Releases for Testicular

Global Testicular Implants Market Size & Forecasts to 2026
As per the studies conducted by GME, the Testicular Implants Market will grow at a CAGR value of 3.2% i.e with a slow-moderate growth rate in the 2020 to 2026 time frame. Testicular implantation is a surgery in which prosthetic testicles are artificially placed for those patients who do not possess natural testicles or who have lost them due to injury, accident, cancer, or any form of surgery related to
Global Testicular Implant Market 2016 - A Growth Research Report
This report studies Testicular Implant in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering AART Allied Biomedical Coloplast Nagor Polytech Health & Aesthetics Promedon Sebbin UROMED Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Testicular Implant in these regions, from 2011 to
Testicular cancer Market Insights, Epidemiology, Industry Trends and Forecast 20 …
"The Latest Research Report Testicular cancer-Market Insights, Epidemiology and Market Forecast-2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" DelveInsights Testicular cancer-Market Insights, Epidemiology and Market Forecast-Market Insights, Epidemiology and Market Forecast-2025 report provides an overview of the disease and in depth research related to Testicular cancer-Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and
Testicular Cancer Drugs Market to increase rapidly by 2023
Testicular cancer is observed in males aged between 15 to 44 years where major symptoms include forming a painless lump or swelling in testicles. If the cancer is left untreated, the eventual course is metastasis and mortality. However, due to advances in multimodal treatments which include surgery, radiation and chemotherapy, a cure for this type of cancer is commonly achieved. Testicular cancer is classified into different types of cancer depending
Testicular Cancer Drugs Market Research Report- Forecast to 2023
Testicular cancer is observed in males aged between 15 to 44 years where major symptoms include forming a painless lump or swelling in testicles. If the cancer is left untreated, the eventual course is metastasis and mortality. However, due to advances in multimodal treatments which include surgery, radiation and chemotherapy, a cure for this type of cancer is commonly achieved. Testicular cancer is classified into different types of cancer depending
Testicular Cancer Drugs Market: Global Industry Analysis 2023
Testicular cancer is observed in males aged between 15 to 44 years where major symptoms include forming a painless lump or swelling in testicles. If the cancer is left untreated, the eventual course is metastasis and mortality. However, due to advances in multimodal treatments which include surgery, radiation and chemotherapy, a cure for this type of cancer is commonly achieved. Testicular cancer is classified into different types of cancer depending